• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.p53和HER-2/neu蛋白的过表达作为早期乳腺癌的预后标志物。
Ann Surg. 1995 Apr;221(4):433-5.
2
HER-2/neu overexpression in breast cancer: an immunohistochemical study including correlations with clinicopathologic parameters, p53 oncoprotein and cathepsin-D.乳腺癌中HER-2/neu过表达：一项免疫组织化学研究，包括与临床病理参数、p53癌蛋白和组织蛋白酶D的相关性。
Anticancer Res. 2001 May-Jun;21(3C):2207-12.
3
Mitochondrial DNA alterations correlate with the pathological status and the immunological ER, PR, HER-2/neu, p53 and Ki-67 expression in breast invasive ductal carcinoma.线粒体DNA改变与乳腺浸润性导管癌的病理状态以及免疫组化雌激素受体（ER）、孕激素受体（PR）、人表皮生长因子受体2（HER-2/neu）、p53和Ki-67表达相关。
Oncol Rep. 2015 Jun;33(6):2924-34. doi: 10.3892/or.2015.3887. Epub 2015 Mar 31.
4
Expression of cyclooxygenase-2 in breast carcinogenesis and its relation to HER-2/neu and p53 protein expression in invasive ductal carcinoma.环氧化酶-2在乳腺癌发生中的表达及其与浸润性导管癌中HER-2/neu和p53蛋白表达的关系。
Breast. 2006 Jun;15(3):390-8. doi: 10.1016/j.breast.2005.06.011. Epub 2005 Sep 19.
5
Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.肿瘤组织学类型和分期而非p53、Her2-neu或组织蛋白酶D的表达是乳腺癌患者独立的预后因素。
Anticancer Res. 2004 May-Jun;24(3b):2061-8.
6
Prognostic value of immunohistochemical expression of topoisomerase alpha II, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu in adrenal and extra-adrenal pheochromocytomas.拓扑异构酶α II、MIB-1、p53、E-钙黏蛋白、视网膜母细胞瘤基因蛋白产物及HER-2/neu在肾上腺及肾上腺外嗜铬细胞瘤中的免疫组化表达的预后价值
Appl Immunohistochem Mol Morphol. 2000 Dec;8(4):267-74.
7
HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancer.雌激素受体阳性、淋巴结阳性乳腺癌中HER-2/neu和p53表达与他莫昔芬耐药性的关系
J Clin Oncol. 2000 Oct 15;18(20):3471-9. doi: 10.1200/JCO.2000.18.20.3471.
8
Differences in the pathologic and molecular features of intraductal breast carcinoma between younger and older women.年轻女性与年长女性乳腺导管内癌在病理及分子特征上的差异。
Cancer. 2003 Mar 15;97(6):1393-403. doi: 10.1002/cncr.11204.
9
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis.p53、表皮生长因子受体（EGFR）和人表皮生长因子受体2/神经（HER-2/neu）对上皮性卵巢癌预后的适度影响：一项荟萃分析
Br J Cancer. 2009 Jul 7;101(1):149-59. doi: 10.1038/sj.bjc.6605112. Epub 2009 Jun 9.
10
Prognostic markers for survival after high-dose chemotherapy with autologous stem-cell transplantation for breast cancer.乳腺癌自体干细胞移植大剂量化疗后生存的预后标志物。
Ann Oncol. 2003 Feb;14(2):341. doi: 10.1093/annonc/mdg053.

引用本文的文献

1
No significant correlation between oncogene protein expression and nodal status.癌基因蛋白表达与淋巴结状态之间无显著相关性。
Ann Surg. 1996 Nov;224(5):686-8. doi: 10.1097/00000658-199611000-00015.

本文引用的文献

1
Immunohistochemical Detection of p53 and c-erbB-2 Proteins: Prognostic Significance in Operable Breast Cancer.p53和c-erbB-2蛋白的免疫组织化学检测：对可手术乳腺癌的预后意义
Breast Cancer. 1994 Jul 30;P(P):17-23. doi: 10.1007/BF02967370.
2
Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.p53和HER-2/neu蛋白的过表达作为早期乳腺癌的预后标志物
Ann Surg. 1994 Apr;219(4):332-41. doi: 10.1097/00000658-199404000-00002.
3
Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update.腋窝阳性淋巴结数量与原发性乳腺癌患者预后的关系。NSABP最新进展。
Cancer. 1983 Nov 1;52(9):1551-7. doi: 10.1002/1097-0142(19831101)52:9<1551::aid-cncr2820520902>3.0.co;2-3.
4
P53 expression in breast cancer.乳腺癌中的P53表达
Int J Cancer. 1988 Feb 15;41(2):178-83. doi: 10.1002/ijc.2910410204.
5
p53 expression in human breast cancer related to survival and prognostic factors: an immunohistochemical study.人乳腺癌中p53表达与生存及预后因素的关系：一项免疫组织化学研究
J Pathol. 1991 May;164(1):75-81. doi: 10.1002/path.1711640113.
6
Relation between p53 overexpression and established prognostic factors in breast cancer.p53过表达与乳腺癌既定预后因素之间的关系。
Surgery. 1991 Aug;110(2):259-64.
7
Nuclear p53 immunoreaction associated with poor prognosis of breast cancer.核p53免疫反应与乳腺癌预后不良相关。
Jpn J Cancer Res. 1991 Jul;82(7):835-40. doi: 10.1111/j.1349-7006.1991.tb02710.x.
8
Expression of ras Rb1 and p53 proteins in human breast cancer.
Anticancer Res. 1992 Jan-Feb;12(1):81-9.
9
C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer.
Cancer. 1992 Jun 15;69(12):2953-60. doi: 10.1002/1097-0142(19920615)69:12<2953::aid-cncr2820691214>3.0.co;2-u.
10
Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.p53肿瘤抑制基因蛋白的积累：乳腺癌预后的独立标志物。
J Natl Cancer Inst. 1992 Jun 3;84(11):845-55. doi: 10.1093/jnci/84.11.845.

Overexpression of p53 and HER-2/neu proteins as prognostic markers in early stage breast cancer.

作者信息

Noguchi M

出版信息

Ann Surg. 1995 Apr;221(4):433-5.

PMID:7726682
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1234605/
Abstract
摘要